The effect of hyperbaric oxygen treatment on the inflammatory changes caused by intraperitoneal meconium

B Tokar1, A H Gundogan, H Ilhan

  • 1Department of Pediatric Surgery, Osmangazi University School of Medicine, Eskisehir, Turkey. btokar@ogu.edu.tr

Insights

Hyperbaric oxygen (HBO) treatment may benefit patients with meconium peritonitis by reducing intestinal inflammation and dilation. This study investigated HBO

Area of Science:

  • Peritoneal inflammation
  • Gastrointestinal pathology
  • Hyperbaric medicine

Background:

  • Meconium exposure in the peritoneal cavity triggers significant inflammation.
  • Meconium peritonitis (MP) is a serious condition requiring effective treatment.
  • The role of hyperbaric oxygen (HBO) in MP management is not well-established.

Purpose of the Study:

  • To investigate the effects of intraperitoneal meconium on intestinal morphology and plasma nitrite/nitrate levels.
  • To determine if HBO treatment can mitigate the inflammatory response in meconium peritonitis.
  • To evaluate HBO as an adjunctive therapy for meconium peritonitis.

Main Methods:

  • Rats were divided into three groups: meconium peritonitis (MP), control (saline), and MP with HBO treatment.
  • Meconium or saline was injected intraperitoneally for 3 days.
  • HBO treatment was administered for 7 days concurrently with meconium injection in the HBO group.

Main Results:

  • No bacterial growth was detected in peritoneal cultures across all groups.
  • Plasma nitrite/nitrate levels were significantly different between all groups (MP vs. HBO, MP vs. control, HBO vs. control).
  • MP group showed significant intestinal dilation and serosal thickening with edema and cellular infiltration, which were ameliorated in the HBO group.

Conclusions:

  • HBO treatment significantly reduced plasma nitrite/nitrate levels and ameliorated inflammatory changes in the intestine.
  • HBO therapy demonstrated a beneficial effect in reducing intestinal dilation associated with meconium peritonitis.
  • HBO may serve as a valuable adjunctive treatment for meconium peritonitis.

Related Concept Videos